SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001047469-99-003585
Filing Date
1999-02-05
Accepted
1999-02-05 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A SC 13D/A 25509
  Complete submission text file 0001047469-99-003585.txt   27479
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45277 | Film No.: 99522869
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice